Felix S.F. Ram, PhD, Clinical Pharmacologist
GIM/FP/GP:
Pulmonology:
Ram FS. Review: Oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD. Ann Intern Med. 2011;155:JC3–2. doi: https://doi.org/10.7326/0003-4819-155-6-201109200-02002
Download citation file:
© 2019
Published: Ann Intern Med. 2011;155(6):JC3-2.
DOI: 10.7326/0003-4819-155-6-201109200-02002
Chronic Obstructive Airway Disease, Pulmonary/Critical Care.
Results provided by: